Correlation Between Defence Therapeutics and NervGen Pharma
Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Defence Therapeutics and NervGen Pharma Corp, you can compare the effects of market volatilities on Defence Therapeutics and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and NervGen Pharma.
Diversification Opportunities for Defence Therapeutics and NervGen Pharma
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Defence and NervGen is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and NervGen Pharma go up and down completely randomly.
Pair Corralation between Defence Therapeutics and NervGen Pharma
Assuming the 90 days horizon Defence Therapeutics is expected to generate 0.08 times more return on investment than NervGen Pharma. However, Defence Therapeutics is 11.95 times less risky than NervGen Pharma. It trades about 0.21 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about -0.02 per unit of risk. If you would invest 40.00 in Defence Therapeutics on September 14, 2024 and sell it today you would earn a total of 1.00 from holding Defence Therapeutics or generate 2.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Defence Therapeutics vs. NervGen Pharma Corp
Performance |
| Timeline |
| Defence Therapeutics |
| NervGen Pharma Corp |
Defence Therapeutics and NervGen Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Defence Therapeutics and NervGen Pharma
The main advantage of trading using opposite Defence Therapeutics and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.| Defence Therapeutics vs. Sino Biopharmaceutical Ltd | Defence Therapeutics vs. Institute of Biomedical | Defence Therapeutics vs. Aileron Therapeutics | Defence Therapeutics vs. Enlivex Therapeutics |
| NervGen Pharma vs. Sino Biopharmaceutical Ltd | NervGen Pharma vs. Defence Therapeutics | NervGen Pharma vs. Aileron Therapeutics | NervGen Pharma vs. Enlivex Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |